Keyphrases
Adverse Events
20%
Afatinib
90%
Aging
27%
Aging Phenotype
45%
Cancer Causes
12%
Cancer Clinical Trials
52%
Cancer Mortality
12%
Cancer Treatment
13%
CiteScore
10%
Clinical Perspective
45%
Clinical Trial Registry
96%
Clinical Trials
100%
Core Outcome Set
45%
Data Statistics
10%
Descriptive Statistics
14%
Drug Development
90%
Head-and-neck
13%
High-quality Research
12%
Inferential Statistics
10%
Instructions to Authors
10%
Journal Editors
10%
Knowledge Perception
10%
Knowledge Use
10%
Lung Cancer
30%
Monotherapy
13%
Multiphysics Object-oriented Simulation Environment (MOOSE)
12%
Negative Trials
13%
Nephrology
90%
Non-small Cell Lung Cancer (NSCLC)
20%
Obesity
45%
Patient Benefit
90%
Patient Outcomes
90%
Patient Risk
90%
Premature Aging
45%
PRISMA
23%
PRISMA-P
12%
Prostate Cancer
45%
Reporting Guidelines
90%
Research Quality
20%
Risk Outcomes
90%
Risk-benefit
90%
Sarcopenic Obesity
45%
Scopus
10%
Sectional Analysis
45%
Squamous Cell Carcinoma of Head
13%
STROBE
19%
Subgroup Analysis
10%
Treatment Burden
12%
Trialists
45%
Web-based Survey
45%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
27%
Afatinib
90%
Breast Cancer
13%
Clinical Trial
99%
Disease
6%
Drug Development
90%
Lung Cancer
43%
Malignant Neoplasm
64%
Monotherapy
13%
Non Small Cell Lung Cancer
7%
Off-Label Use
6%
Overall Survival
7%
Prevalence
7%
Progression Free Survival
7%
Prostate Cancer
45%
Squamous Cell Carcinoma
13%
